These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23908381)

  • 21. Repeated randomization and matching in multi-arm trials.
    Xu Z; Kalbfleisch JD
    Biometrics; 2013 Dec; 69(4):949-59. PubMed ID: 24134592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical power and sample size requirements for three level hierarchical cluster randomized trials.
    Heo M; Leon AC
    Biometrics; 2008 Dec; 64(4):1256-62. PubMed ID: 18266889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.
    Brookes ST; Whitely E; Egger M; Smith GD; Mulheran PA; Peters TJ
    J Clin Epidemiol; 2004 Mar; 57(3):229-36. PubMed ID: 15066682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of methods to analyse continuous data from pseudo cluster randomized trials.
    Teerenstra S; Moerbeek M; Melis RJ; Borm GF
    Stat Med; 2007 Sep; 26(22):4100-15. PubMed ID: 17328006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
    Dilba G; Bretz F; Hothorn LA; Guiard V
    Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of adaptive two-stage double-arm clinical trials for dichotomous variables.
    Jiang Z; Xue F; Li C; Wang L; Cai H; Zhang C; Xia J
    Contemp Clin Trials; 2010 May; 31(3):242-50. PubMed ID: 20172053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the statistical power of different methods for the analysis of cluster randomization trials with binary outcomes.
    Austin PC
    Stat Med; 2007 Aug; 26(19):3550-65. PubMed ID: 17238238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing completely and stratified randomized designs in cluster randomized trials when the stratifying factor is cluster size: a simulation study.
    Lewsey JD
    Stat Med; 2004 Mar; 23(6):897-905. PubMed ID: 15027079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A bootstrap-based test for establishing noninferiority in clinical trials.
    Chen M; Kianifard F; Dhar SK
    J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials.
    Diehr P; Chen L; Patrick D; Feng Z; Yasui Y
    Contemp Clin Trials; 2005 Feb; 26(1):45-58. PubMed ID: 15837452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling the family-wise error rate in multi-arm, multi-stage trials.
    Crouch LA; Dodd LE; Proschan MA
    Clin Trials; 2017 Jun; 14(3):237-245. PubMed ID: 28545335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective exclusion of treatment arms in multi-arm randomized clinical trials.
    Law MG; Emery S
    Stat Med; 2003 Jan; 22(1):19-30. PubMed ID: 12486749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized two-stage Phase II clinical trial designs based on Barnard's exact test.
    Shan G; Ma C; Hutson AD; Wilding GE
    J Biopharm Stat; 2013; 23(5):1081-90. PubMed ID: 23957517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dichotomizing a continuous outcome in cluster randomized trials: impact on power.
    Caille A; Leyrat C; Giraudeau B
    Stat Med; 2012 Oct; 31(24):2822-32. PubMed ID: 22733454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size calculator for cluster randomized trials.
    Campbell MK; Thomson S; Ramsay CR; MacLennan GS; Grimshaw JM
    Comput Biol Med; 2004 Mar; 34(2):113-25. PubMed ID: 14972631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size calculations for the design of cluster randomized trials: A summary of methodology.
    Gao F; Earnest A; Matchar DB; Campbell MJ; Machin D
    Contemp Clin Trials; 2015 May; 42():41-50. PubMed ID: 25766887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A powerful and robust test statistic for randomization inference in group-randomized trials with matched pairs of groups.
    Zhang K; Traskin M; Small DS
    Biometrics; 2012 Mar; 68(1):75-84. PubMed ID: 21732926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Planning a cluster randomized controlled trial: methodological issues.
    Christie J; O'Halloran P; Stevenson M
    Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Issues in the meta-analysis of cluster randomized trials.
    Donner A; Klar N
    Stat Med; 2002 Oct; 21(19):2971-80. PubMed ID: 12325113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.